Progressive dystonia in a 12-year-old boy

European Journal of Paediatric Neurology

Volumn 7, Issue 2, 2003, Pages 85-88

  Klepper, Jörg ^a   Schaper, Jörg ^a   Raca, Gordana ^b   Coryell, Jason ^c   Das, Soma ^b   Hayflick, Susan J ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Eye of the tiger; Pantothenate kinase associated neurodegeneration; PKAN; Progressive dystonia

Indexed keywords

COENZYME A; IRON; PANTOTHENATE KINASE;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEVELOPMENTAL COORDINATION DISORDER; DIAGNOSTIC ERROR; DYSARTHRIA; DYSTONIA; EARLY DIAGNOSIS; EMOTIONAL DISORDER; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GLOBUS PALLIDUS; HUMAN; IRON STORAGE; MALE; MENTAL DETERIORATION; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PATHOPHYSIOLOGY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE HOMOLOGY; TREATMENT PLANNING; VOLUNTARY MOVEMENT;

EID: 0037273847     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3798(03)00019-9     Document Type: Article

References (15)

1. Hallervorden J, Spatz H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra: Ein Beitrag zu den Beziehungen zwischen diesen beiden Zentren. Z Ges Neurol Psychiat 1922;79:254-302.
2. Gordon N. Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome). Eur J Paediatr Neurol 2002;6:243-7.
3. Angelini L, Nardocci N, Rumi V, et al. Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life. J Neurol 1992;239:417-25.
4. Swaiman KF. Hallervorden-Spatz syndrome. Pediatr Neurol 2001;25:102-8.
5. Casteels I, Spileers W, Swinnen T, et al. Optic atrophy as the presenting sign in Hallervorden-Spatz syndrome. Neuropediatrics 1994;25:265-7.
6. Guillerman RP. The eye-of-the-tiger sign. Radiology 2000;217:895-6.
7. Littrup PJ, Gebarski SS. MR imaging of Hallervorden-Spatz disease. J Comput Assist Tomogr 1985;9:491-3.
8. Mink JW. Basal ganglia motor function in relation to Hallervorden-Spatz syndrome. Pediatr Neurol 2001;25:112-7.
9. Koeppen AH, Dickson AC. Iron in the Hallervorden-Spatz syndrome. Pediatr Neurol 2001;25:148-55.
10. Zhou B, Westaway SK, Levinson B, et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nature Genet 2001;28:345-9.
11. Rouault TA. Iron on the brain (Comment). Nature Genet 2001;28:299-300.
12. Hayflick SJ. First scientific workshop on Hallervorden-Spatz syndrome: executive summary Pediatr Neurol 2001;25:99-101.
13. Shevell MI, Peiffer J. Julius Hallervorden's wartime activities: implications for science under dictatorship. Pediatr Neurol 2001;25:162-5.
14. Seidelman WE. Medspeak for murder. The Nazi experience and the culture of medicine. In: Caplan AL, ed. When Medicine went Mad: Bioethics and the Holocaust. Totowa, NJ: Humana Press; 1992:271-9.
15. Harper PS. Naming of syndromes and unethical activities: the case of Hallervorden and Spatz. Lancet 1996;348:1224-5.